DNA Bridges, Inc. is a
leading corporate development firm that leverages seasoned
scientific and business talent in the life sciences, device and
pharmaceutical industries to bridge science and products.
FROM DISCOVERY TO LAUNCH
our team has developed and supported the commercialization
of products with combined sales over $10 billion USD. These
include Herceptin, Xolair, Activase, Raptiva and Kogenate.
INDUSTRY & CLIENT NEWS